Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2007-09-04
2007-09-04
Chan, Christina (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387300
Reexamination Certificate
active
09847208
ABSTRACT:
The invention concerns bifunctional fusion molecules for the treatment of IgE-mediated allergic conditions and FcεRI-mediated autoimmune conditions. The invention provides a new therapeutic approach for the treatment of both acute and late-phase allergic responses due to ingestion, inhalation, cutaneous and parenteral exposure to allergens, responses including asthma, allergic rhinitis, atopic dermatitis, severe food allergies, chronic urticaria and angioedema, as well as anaphylactic reactions due to exposures such as bee stings or penicillin allergy. In addition, the invention provides for a novel, safer and more efficacious form of allergy vaccination.
REFERENCES:
patent: 5017693 (1991-05-01), Hylarides et al.
patent: 5116964 (1992-05-01), Capon et al.
patent: 5141648 (1992-08-01), Hylarides et al.
patent: 5329028 (1994-07-01), Ashkenazi et al.
patent: 5336603 (1994-08-01), Capon et al.
patent: 5358710 (1994-10-01), Sehon et al.
patent: 5420247 (1995-05-01), Gearing et al.
patent: 5512283 (1996-04-01), Byers et al.
patent: 5558869 (1996-09-01), Burks, Jr. et al.
patent: 5560915 (1996-10-01), Patterson et al.
patent: 5563250 (1996-10-01), Hylarides et al.
patent: 5565335 (1996-10-01), Capon et al.
patent: 5637454 (1997-06-01), Harley
patent: 5645820 (1997-07-01), Halfer et al.
patent: 5672683 (1997-09-01), Friden et al.
patent: 5736507 (1998-04-01), Boots et al.
patent: 5811265 (1998-09-01), Quertermous et al.
patent: 5827516 (1998-10-01), Urban et al.
patent: 5843449 (1998-12-01), Boots et al.
patent: 5869093 (1999-02-01), Weiner et al.
patent: 5880103 (1999-03-01), Urban et al.
patent: 5925351 (1999-07-01), Browning et al.
patent: 5945294 (1999-08-01), Frank et al.
patent: 5965605 (1999-10-01), Cheng et al.
patent: 5977307 (1999-11-01), Friden et al.
patent: 6043345 (2000-03-01), Saxon et al.
patent: 6093699 (2000-07-01), Sehon et al.
patent: 6103697 (2000-08-01), Bergstrand et al.
patent: 6214974 (2001-04-01), Rosenblum et al.
patent: 6228373 (2001-05-01), Bergstrand et al.
patent: 6228374 (2001-05-01), Bergstrand et al.
patent: 6287792 (2001-09-01), Pardridge et al.
patent: 6372250 (2002-04-01), Pardridge et al.
patent: 2001/0053770 (2001-12-01), Thomas et al.
patent: 2003/0049237 (2003-03-01), Bannon et al.
patent: 2003/0077282 (2003-04-01), Bigler et al.
patent: 2004/0198961 (2004-10-01), An et al.
patent: 2005/0250934 (2005-11-01), Wang et al.
patent: WO88/09344 (1988-12-01), None
patent: WO95/14779 (1995-06-01), None
patent: WO96/12740 (1996-05-01), None
patent: 96/22024 (1996-07-01), None
patent: WO96/26961 (1996-09-01), None
patent: WO96/40789 (1996-12-01), None
patent: 99/02709 (1999-01-01), None
patent: 99/02710 (1999-01-01), None
patent: 99/02711 (1999-01-01), None
patent: WO99/67293 (1999-12-01), None
patent: WO 00/05254 (2000-02-01), None
patent: WO 02/102320 (2002-12-01), None
patent: WO 02/102320 (2002-12-01), None
Krauss et al., Eur J Immunol 25(1): 192-9, Jan. 1995.
Basu et al., J boil Chem 268(18): 13118-27, Jun. 1993.
Ngo et al., in The Protein Folding Problem and Tertiary Structure Prediction, 1994, Merz, et al., (ed.), Birkhauser, Boston, MA, pp. 433 and 492-495.
Skolnick et al., From genes to protein structure and function: novel applications of computational approaches in the genomic era, Jan. 2000, Trends in Biotech. 18(1): 34-39.
Wallace et al., Methods Enzymol 152: 432-441, 1987.
Stevenson et al., J Immunol 158(5): 2242-50, Mar. 1997.
Daeron et al, J Clin Invest 95(2): 577-85, Feb. 1995.
Adamczewski, M., and Kinet, J.P., The High-Affinity Receptor for Immunoglobulin EChemical Immun., 59:173-190 (1994).
Arm et al.,Molecular Cloning of gp49, a Cell-surface Antigen That Is Preferentially Expressed by Mouse Mast Cell Progenitors and Is a New Member of the Immunoglobulin SuperfamilyJ. Biol. Chem. 266:15966-73 (1991).
Barnes, Peter, “Anti-IgE Antibody Therapy for Asthma”The New England Journal of Medicine341:2006-2008 (1999).
Beasley et al.,prevalence and Etilogy of asthmaJ. Allergy Clin. Immunol. 105:466-472 (2000).
Blondel, A. and Bedouelle,Engineering the quaternary structure of an exported protein with a leucine zipperProtein Engineering4:457-461 (1991).
Burks, et al. “Mapping and mutational analysis of the IgE-binding epitopes on Ara h 1, a legume vicilin and a major allergen in peanut hypersensitivity”Eur. J. Biochem. 245:334-339 (1997).
Cambier, J.C., Inhibitory receptors abound?Proc. Natl. Acad. Sci. USA94:5992-5995 (1997).
Casares et al. “Engineering an characterization of a murine MGC class II-immunoglobulin chimera expressing an immunodominant CD4 T viral epitope”Protein Engineering10(11):1295-1301 (1997).
Casares et al., “Antigen-specific Signaling by a Soluble, Dimeric Peptide/Major Histocompatibility Complex Class II/Fc Chimera Leading to T helper Cell Type 2 Differenciation”J. Exp. Med. 190:543-553 (Nov. 1999).
Costa et al., The IgE-binding epitopes of rPar j2, a major allergen of Parietaria judaica polen, are heterogeneously recognized among allergic subjects Allergy 55:246-50 (2000).
Daeron et al. “The Same Tyrosine-Based Inhibition Motif, in the Intra-cytoplasmic Domain of FCγRIIB, Regulates Negatively BCR-,TCR-, and FcR-Dependent Cell Activation”Immunity, 3:635-646 (Nov. 1995).
Daeron et al.., “Regulation of High-affinity IgE Receptor-mediated Mast Cell Activation by Murine Low-affinity IgG Receptors”.J. Clin. Invest95:577-585 (Feb. 1995).
De Lara, J.M. Tunon, “Immunoglobulines E et cellules de l'inflamation”Rev. Mal. Resp. 13:27-36 (1996).
Ellison and Hood., Linkage and sequence homology of two human immunoglobulin γ heavy chain constant region genesProc. Nat. Acad. Sci. USA79:1984-1988 (1982).
Ellison et al., “The nucleotide sequence of a human immuniflobulin cγl gene”Nucl. Acids Res. 10(13):4071-4079 (1982).
Fiebiger et al., Serum IgG Autoantibodies Directed against the α Chain of a Fcε RI: A Selective Marker and Pathogenic Factor for a Distinct Subset of Chronic Urticaria PatientsThe Journal of Clinical Investigation96:2006-2612 (Dec. 1995).
Fiebiger et al., “Anti-FcεRIα Autoantibodies in Autoimmune-mediated Disorders Identification of a Structure-Function Relationship”J. Clin. Invest. 101:243-251 (Jan. 1998).
Fridman, W., “Fc Receptors and Immunoglobulin binding factors”FASEB J., 5(12):2684-90 (1991).
Gerber , Jeffrey and Mosser, David, Reversing Lipopolysaccharide Toxicitu by Ligating the Macrophage Fcγ ReceptorsThe Journal of Immunology6861-6868 (2001).
Hayami et al., Molecular Cloning og a Novel Murine Cell-surface Glycoportein Homologous to Killer Cell Inhibitory ReceptorsJ. Biol. Chem. 272:7320-7 (1997).
Hide et al.,Autoantibodies against the high-affinity IgE receptor as a cause of histamine release inchronic urticariaN. Engl. J. Med. 328:1599-1604 (1993).
Kikutani et al. “Molecular Structure of Human Lymphocyte Receptor for Immunoglobulin E”Cell47:657-665 (Dec. 1996).
Kondo et al. “Cloning of cDNAs for New Subtypes of Murine Low-Affinity Tc Receptor for IgE (FcεRIL/CG23)”Int. Arch. Immunol. 105:38-48 (1994).
Krawinkel an Rabbitts, “Comparison of the hinge-coding segments in human immunoglobulin gamma heavy chjain genes and the linkage of the gamma 2 and gamma 4 subclass genes” The EMBO 1(4):403-307 (1982).
Landschulz, W. H., et al., The Leucine Zipper: A Hypothetical Structure Common to a New Class of DNA Binding ProteinsScience240:1759-1764 (1988).
Legge et al., Coupling of Peripheral Tolerance to Endogenous Interleukin 10 Promotes Effective Modulation of Nyelin-activated T Cells an Ameliorates Experimental Allergic EncephalomyelitisJ. Exp. Med. 191(12):2039-2051 (Jun. 2000).
Legge et al., Presentation of a T Cell Receptor Antagonist Peptide by Immunoglobulins Ablates Activation of T Cells by a Synthetic Peptide or Proteins Requiring Endicytic ProcessingJ. Exp. Med. 185(6):1043-1053 (Mar. 1997).
Ludin et al.,Cloning and expression of the cDNA coding for a human lymphocyte Ige recepto
Saxon Andrew
Zhang Ke
Zhu Daocheng
Chan Christina
Dreger Ginger R.
Heller Ehrman LLP
Huynh Phuong
The Regents of the University of California
LandOfFree
Fusion molecules and treatment of IgE-mediated allergic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fusion molecules and treatment of IgE-mediated allergic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fusion molecules and treatment of IgE-mediated allergic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3767538